Improved screening for cystic fibrosis-related diabetes by an integrated care team using an algorithm

Maria Socorro Rayas1, Donna Beth Willey-Courand, Jane Lockwood Lynch

  • 1Division of Pediatric Endocrinology and Diabetes, University of Texas Health Science Center in San Antonio, San Antonio, Texas.

Pediatric Pulmonology
|January 18, 2014
PubMed

Insights

A new algorithm improved cystic fibrosis-related diabetes (CFRD) screening compliance initially. However, this improvement was not sustained long-term, highlighting the need to address patient barriers.

Area of Science:

  • Pediatric Endocrinology
  • Pulmonology
  • Quality Improvement Science

Background:

  • Cystic fibrosis-related diabetes (CFRD) screening is crucial for early detection and management.
  • Current screening guidelines adherence can be variable in clinical practice.

Purpose of the Study:

  • To evaluate the effectiveness of a standardized, clinic-based algorithm in improving compliance with CFRD screening guidelines.
  • To assess the impact of the algorithm on oral glucose tolerance test (OGTT) completion rates in pediatric CF patients.

Main Methods:

  • A quality improvement initiative developed and implemented a prospective CFRD screening algorithm for children aged 8-17 years over 6 months.
  • The primary outcome was the rate of appropriately screened patients (OGTT completion) during the intervention period compared to the prior year.

Main Results:

  • Algorithm implementation significantly increased OGTT completion rates (P=0.03) during the initial 6-month period.
  • While provider ordering compliance remained high (97%), patient completion rates decreased in the year following implementation (79%), showing no significant improvement over baseline (P=0.08).

Conclusions:

  • A standardized algorithm initially improved CFRD screening compliance.
  • The positive impact on patient screening was not sustained long-term, indicating potential barriers to patient adherence that require further investigation.
Abstract

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
657
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
924
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K